immutep (asx:imm) esmo congress results webinar, october 2023
Published 11 months ago • 15 plays • Length 50:22Download video MP4
Download video MP3
Similar videos
-
50:22
immutep (asx:imm, nasdaq:immp) esmo congress results webinar, 23 october 2023
-
15:49
immutep (asx:imm) - webinar presentation
-
16:07
immutep (asx:imm) - webinar presentation
-
16:06
immutep (asx:imm) - webinar presentation
-
7:09
immutep (asx:imm) reports 71.4% response rate for lung cancer therapy
-
5:04
imugene (asx:imu) | jmm & éthica capital innovation interview \ may 2024
-
5:19
cramer: this biotech stock could be worth over $100 billion on an fda approval
-
5:56
understanding psma/pet, axumin, mri, ultrasound | ask a prostate expert, mark scholz, md
-
50:47
immutep esmo congress 2023 update #immp lung center
-
4:32
immutep (asx:imm) company update
-
3:33
immutep (asx:imm) reports positive trial data
-
1:14:06
immutep (asx:imm) sitc 2021 results - management update
-
5:18
expert video report on amivantamab in combination therapy for 1l treatment in egfrm, advanced nsclc
-
4:54
immutep (asx:imm) 1h20 results & outlook
-
5:07
immutep (asx:imm) clinical trial program milestones
-
10:55
immutep (asx:imm) presentation, fnn investor event, may 2022
-
16:22
immutep limited - asx small & mid cap conference
-
7:58
immutep: a leader in a league alongside global pharma giants
-
2:01
esmo asia 2024 – unveiling the programme highlights. prof hanneke van laarhoven & prof nadia harbeck
-
2:04
acquired resistance to osimertinib in t790m-positive nsclc